T1D Exchange and M2D2 Open the Diabetes Innovation Challenge Request for Applicants

Ambitious initiative aims to excite and incentivize researchers, inventors, entrepreneurs, investors, and the industry to innovate new and inventive approaches to combat diabetes at the inaugural Diabetes Innovation Challenge Boston, MA – June 1, 2016 – T1D Exchange, an organization that is accelerating research to improve outcomes in type 1 diabetes, and M2D2, a joint [...]

Erin Gilbert Named Chief Advancement Officer for Unitio

Proven executive will expand the innovative organization’s development strategies in support of mission to improve health outcomes and quality of life BOSTON, MA, May 3, 2016 - Erin Gilbert has been named the Chief Advancement Officer of Unitio, Inc., a nonprofit organization who unites those affected by disease with those dedicated to accelerating better care [...]

Lilly plans to take Locemia Solution’s needle-free glucagon to market

How T1D Exchange and its patient communities played a role in advancing intranasal glucagon T1D Exchange congratulates two of our member companies, Lilly and Locemia Solutions. Lilly acquired Phase III Intranasal Glucagon from Locemia Solutions. Intranasal glucagon is a potential treatment for severe hypoglycemia in people with diabetes who use insulin and could be the [...]

T1D Exchange Biobank Samples: Helping Researchers Better Understand Type 1 Diabetes

The T1D Exchange Biobank consists of thousands of biological samples and clinical, demographic, and study-derived information from individuals with T1D. It’s an important resources for innovative research, and promotes the exchange of knowledge and collaboration. More than 2,100 members of the Living Biobank (individuals with T1D who have agreed to have their blood collected when [...]